AZD8055 for Adults With Recurrent Gliomas

NCT01316809 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

NIH

Sponsor class

Conditions

Glioblastoma Multiforme
Anaplastic Astrocytoma
Anaplastic Oligodendroglioma
Malignant Glioma
Brainstem Glioma

Interventions

DRUG: AZD8055

Sponsor

National Cancer Institute (NCI)